MC1385A1 - Combinaisons de substances actives - Google Patents

Combinaisons de substances actives

Info

Publication number
MC1385A1
MC1385A1 MC811523A MC1523A MC1385A1 MC 1385 A1 MC1385 A1 MC 1385A1 MC 811523 A MC811523 A MC 811523A MC 1523 A MC1523 A MC 1523A MC 1385 A1 MC1385 A1 MC 1385A1
Authority
MC
Monaco
Prior art keywords
diamino
pyrimidine
bromo
combinations
active substances
Prior art date
Application number
MC811523A
Other languages
English (en)
French (fr)
Inventor
Erika Boehni
Notterbrock Helene Plozza
Rudolf Then
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1385A1 publication Critical patent/MC1385A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC811523A 1980-06-26 1981-06-23 Combinaisons de substances actives MC1385A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH491680 1980-06-26

Publications (1)

Publication Number Publication Date
MC1385A1 true MC1385A1 (fr) 1982-04-27

Family

ID=4284769

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811523A MC1385A1 (fr) 1980-06-26 1981-06-23 Combinaisons de substances actives

Country Status (10)

Country Link
EP (1) EP0043055A1 (enExample)
JP (1) JPS5732220A (enExample)
AU (1) AU7196881A (enExample)
CU (1) CU35465A (enExample)
GR (1) GR82351B (enExample)
MC (1) MC1385A1 (enExample)
NZ (1) NZ197475A (enExample)
PH (1) PH16745A (enExample)
ZA (1) ZA814160B (enExample)
ZW (1) ZW10681A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651473A5 (de) * 1982-07-29 1985-09-30 Joachim Karl Prof Dr Seydel Pharmazeutisches praeparat.
HU197986B (en) * 1987-02-25 1989-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing veterinary preparation of synergic effect

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE419444B (sv) * 1973-11-08 1981-08-03 Hoffmann La Roche Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat

Also Published As

Publication number Publication date
ZA814160B (en) 1982-07-28
AU7196881A (en) 1982-01-07
CU35465A (en) 1982-08-24
ZW10681A1 (en) 1982-02-24
JPS5732220A (en) 1982-02-20
NZ197475A (en) 1984-05-31
EP0043055A1 (de) 1982-01-06
GR82351B (enExample) 1984-12-13
PH16745A (en) 1984-02-10

Similar Documents

Publication Publication Date Title
EP1328269B2 (fr) Association d'un antagoniste du recepteur cb1 et de la sibutramine pour le traitement de l'obesite
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
CA2268709A1 (en) Hiv protease inhibitors
ATE237587T1 (de) 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
MA30075B1 (fr) Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
ATE290386T1 (de) Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen
MA27197A1 (fr) Sels de tolterodine
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
RU2009124593A (ru) Полиморфные формы деферасирокса (icl670a)
MC1385A1 (fr) Combinaisons de substances actives
US5369129A (en) Preparation of topical treatment of infections caused by virus, bacteria and fungi
EP0043548B1 (de) Salz aus Furosemid oder Piretanid als Säurekomponente und Penbutolol als Basenkomponente sowie Arzneimittel, das beide Komponenten enthält
MXPA01007705A (es) Derivado de benzamida y medicamento que lo contiene.
WO1990015597A1 (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
CA1059913A (fr) Compositions pharmaceutiques
CA1221635A (fr) Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires
JPS63156724A (ja) 逆転写酵素阻害剤
DE1695376A1 (de) Basische 5,6-Dihydromorphanthridinderivate
EP1998779A2 (fr) Utilisation du (3s)-n-hydroxy-4-({4-ý(4-hydroxy-2-butynyl)oxy]phényl}sulfonyl)-2,2-diméthyl-3-thiomorpholine carboxamide ou du (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide dans le traitement de pathologies inflammatoires cutanées
DE60214414T2 (de) Peptidderivat, pharmazeutisch verträgliches salz davon, verfahren zu dessen herstellung und dessen verwendung
FR2723372A1 (fr) Nouveaux derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
BE818335R (fr) Composition antibacterienne et procede
FR2711526A1 (fr) Utilisation de l'Acriflavine comme agent anti herpès et anti zona.
US4470993A (en) Therapeutical use of known 5-aminomethyl oxazolidine-2-one derivatives

Legal Events

Date Code Title Description
YP Annual fee paid